KELLY NOLIN: Open Payments
NPI 1033627872 · ENFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,644 in 185 payments from 32 companies in 2025. Trend: 2023 $3,512 · 2024 $3,499 · 2025 $3,644
Food & beverage: $3,625Education: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $488 |
| AstraZeneca Pharmaceuticals LP | 13 | $366 |
| PFIZER INC. | 19 | $331 |
| GlaxoSmithKline, LLC. | 11 | $220 |
| Otsuka America Pharmaceutical, Inc. | 12 | $186 |
| Novo Nordisk Inc | 10 | $174 |
| Azurity Pharmaceuticals, Inc. | 8 | $168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $155 |
| Lilly USA, LLC | 7 | $153 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $147 |
Products named: REXULTI, VRAYLAR, NURTEC ODT, AIRSUPRA, TRELEGY ELLIPTA, JARDIANCE, FREESTYLE LIBRE 3, UBRELVY.
Industry payments across CT — which companies pay providers there.
